Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.
Toxicol In Vitro. 2020 Jun;65:104809. doi: 10.1016/j.tiv.2020.104809. Epub 2020 Feb 19.
Disintegrins are low molecular weight cysteine-rich proteins (4-14 kDa) that are isolated mainly from viperid snake venom. Due to their potential as lead compounds for binding and blocking integrin receptors, snake venom disintegrins have become one of the most studied venom protein families. The aim of this study was to obtain disintegrins from C. totonacus venom and evaluate their capability to bind and block integrin receptors. The C. totonacus disintegrin fraction (totonacin) represents two disintegrin isoforms obtained from C. totonacus venom. These disintegrins showed extracellular-matrix (ECM) protein adhesion and migration inhibitory effects on MDA-MB-231 and HMEC-1 cells. Totonacin (3 μM) inhibited MDA-MB-231 cell adhesion to the ECM proteins, fibronectin, vitronectin, and laminin by 31.2, 44.0, and 32.1, respectively. Adhesion inhibition to fibronectin, vitronectin, and laminin observed on HMEC-1 cells was 42.8, 60.8, and 51%, respectively. In addition, totonacin (3 μM) significantly inhibited MDA-MB-231 and HMEC-1 cell migration (41.4 and 48.3%, respectively). Totonacin showed more potent cell adhesion inhibitory activity toward vitronectin in both cell lines. These results suggest a major affinity of totonacin toward αβ, αβ, αβ, αβ, and αβ integrins. In addition, the inhibitory effect observed on MDA-MB-231 and HMEC-1 cell migration reinforces the evidence of an interaction between these disintegrins and αβ integrin, which plays a key role in migration and angiogenesis.
解整合素是一种小分子富含半胱氨酸的蛋白质(4-14 kDa),主要从蝰蛇毒液中分离得到。由于它们具有作为结合和阻断整合素受体的先导化合物的潜力,蛇毒解整合素已成为研究最多的毒液蛋白家族之一。本研究旨在从 C. totonacus 毒液中获得解整合素,并评估其结合和阻断整合素受体的能力。C. totonacus 解整合素部分(totonacin)代表从 C. totonacus 毒液中获得的两种解整合素同工型。这些解整合素对 MDA-MB-231 和 HMEC-1 细胞表现出细胞外基质(ECM)蛋白粘附和迁移抑制作用。Totonacin(3 μM)抑制 MDA-MB-231 细胞对 ECM 蛋白(纤连蛋白、 vitronectin 和层粘连蛋白)的粘附,抑制率分别为 31.2%、44.0%和 32.1%。在 HMEC-1 细胞上观察到对纤连蛋白、vitronectin 和层粘连蛋白的粘附抑制率分别为 42.8%、60.8%和 51%。此外,totonacin(3 μM)显著抑制 MDA-MB-231 和 HMEC-1 细胞迁移(分别为 41.4%和 48.3%)。Totonacin 对两种细胞系中的 vitronectin 具有更强的细胞粘附抑制活性。这些结果表明,totonacin 对 αβ、αβ、αβ、αβ 和 αβ 整合素具有主要亲和力。此外,在 MDA-MB-231 和 HMEC-1 细胞迁移中观察到的抑制作用进一步证实了这些解整合素与 αβ 整合素之间的相互作用,αβ 整合素在迁移和血管生成中起关键作用。